<DOC>
	<DOC>NCT02186561</DOC>
	<brief_summary>The purpose of this study is to assess the safety and effectiveness of the Pipeline™ device in the treatment of unruptured, wide-neck intracranial aneurysms.</brief_summary>
	<brief_title>Prospective Study on Embolization of Intracranial Aneurysms With Pipeline™ Embolization Device</brief_title>
	<detailed_description />
	<mesh_term>Aneurysm</mesh_term>
	<mesh_term>Intracranial Aneurysm</mesh_term>
	<criteria>Subject has provided written informed consent using the IRB/ECapproved consent form and agrees to comply with protocol requirements. Age 2280 years. Subject has a target intracranial aneurysm (IA) located in the anterior or posterior circulation. Subject has a target IA with a wide aneurysm neck. Subject has received an intracranial implant (e.g. coils) in the area of the target IA within the past 12 weeks. Major surgery in the last 30 days. History of irreversible bleeding disorder and/or subject presents with signs of active bleeding. Any known contraindication to treatment with the Pipeline™ device. Pregnant women. Participating in another clinical trial.</criteria>
	<gender>All</gender>
	<minimum_age>22 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>intracranial aneurysm</keyword>
	<keyword>brain aneurysm</keyword>
</DOC>